Gf Fund Management Co. Ltd. Cogent Biosciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,828 shares of COGT stock, worth $20,305. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,828
Previous 2,319
21.95%
Holding current value
$20,305
Previous $18.1 Million
6.35%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding COGT
# of Institutions
196Shares Held
116MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$65.4 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$64.4 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$63.9 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$52.3 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$50 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $472M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...